On December 22, 2010, Krsnaa Diagnostics Limited was founded as ‘Krsna Diagnostics Private Limited’ in Pune, Maharashtra as a private limited entity. In 13 states, around the nation the firm operates 1,801 diagnostic centres and delivered radiology and pathology facilities. Krsnaa Diagnostics IPO will hit the market on 04 August 2021.
Table of Contents
About
Krsnaa Diagnostics, India’s largest public-private partnership, provides a world-class diagnostic service across the country.
Highest standards with prescriptive technical standard specifications directed by the National Accreditation Board for Hospitals and Medical Suppliers NABL, NABH to pursue international safety practices in scanning technology and to guarantee correct results at all times.
Strength is a key quality established at Krsnaa Diagnostics in modern constantly evolving globe.
Journey
What started as a small seed with just two radiology facilities has expanded to include over 1000 radiology centres and 500 pathology centers.
Their extensive staff of renowned radiologists reports more than 70,000 CT/MRI and 5 Lac X-rays each month using their cutting-edge Teleradiology Center.
Their well-trained workforce of about 1000 workers in the facilities is continually evolving to ensure that visitors and recommending clinicians are satisfied with the care they receive.
Their pathology laboratories and centres throughout the nation conduct more than 500000 tests each month using modern, completely automatic machinery.
Vision
To provide international healthcare diagnostics facilities at reasonable costs with the ideology of “Let’s Do Good”.
Mission
“To bring a revolution in healthcare.” by providing scientifically innovative diagnostic technologies and, as a result, reaching out to the people in even the most remote areas, by providing facilities at a 50% discount off the regular market rate.
Service
Krsnaa offers a wide number of radiology, pathology, and tele-radiology facilities, all of which are provided by highly trained and professional personnel.
They meet the expectations of community and their healthcare specifications by combining cutting-edge innovation with highly trained radiologists.
A world-class integrated distribution network is used to provide their facilities. They are constantly working to improve performance, efficiency, and accuracy through innovation.
They have given support to both the public and the corporate industry and their performance speaks for itself.
Krsnaa Diagnostic IPO
Krsnaa Diagnostic limited, headquartered in Pune has submitted Draft Red Herring Prospectus(DRHP) to Securities and Exchange Board of India(SEBI) for initial public offering (IPO) of INR 1,213.76 crore on 15 May 2021.
The Offer includes a fresh equity of Rs. 400 crore and an offer for sell(OFS) up to 9.4 million equity shares of face value of 5 per equity shares by the promoters.
They got approval from Securities and Exchange Board of India(SEBI) on 26 July, 2021 to float the initial public offering (IPO) in the market.
Financials Trends
| Particulars | For the year/period ended ( in Cr.) | ||||
|---|---|---|---|---|---|
| 31-Dec-20 | 31-Mar-20 | 31-Mar-19 | 31-Mar-18 | ||
| Total Assets | 634.52 | 629.98 | 528.99 | 289.97 | |
| Total Revenue | 562.70 | 271.38 | 214.32 | 110.46 | |
| Profit After Tax | 195.93 | (111.95) | (58.06) | (60.16) | |
Basic & Diluted Earnings Per Share
| Financial Period | Basic EPS (in INR) | Diluted EPS (in INR) | Weight |
| Financial Year 2020 | (97.16) | (97.16) | 3 |
| Financial Year 2019 | (53.87) | (53.87) | 2 |
| Financial Year 2018 | (52.19) | (52.19) | 1 |
| Weighted Average | (75.24) | (75.24) | |
| (9 months) Dec. 31, 2020 | 169.96 | 6.51 | – |
Objects of the Issue
- Prepayment / repayment of all or a portion of the outstanding borrowings of 125.7 crore on the company to be availed on consolidated basis.
- To meet common corporate objectives.
- In Punjab, Karnataka, Himachal Pradesh, and Maharashtra, the firm will open diagnostics facilities.
Basis of The offer
- Unique and scaled diagnostics firm.
- Good brand equity.
- Extensive footprint around the nation with robust infrastructure.
- Well positioned to capitalize on healthcare spending around public and private industries.
- Consistent track record of financial achievement.
- Ability to sustain cost competitiveness through operating leverage.
- Experienced promoters and management team supported by professional staff base.
Krsnaa Diagnostic IPO Peer Comparison
| S. No. | Company Name | PE |
| 1 | Dr. Lal PathLabs Limited | 93.33 |
| 2 | Metropolis Healthcare Limited | 101.03 |
Krsnaa Diagnostic IPO Details
| IPO Opening Date | 04 August 2021 |
| IPO Closing Date | 06 August 2021 |
| Issue Type | Book Building |
| Face Value | 5 per share |
| IPO Price | 933 to 954 per equity share |
| Market Lot | 15 |
| Min Order Quantity | 15 |
| Listing At | BSE, NSE |
| Issue Size | Rs. 1,213.76 Crore |
| Fresh Issue | Rs. 400 Crore |
| Offer for Sale | 9.4 million equity shares |
Krsnaa Diagnostics IPO Tentative Date
The Krsnaa Diagnostics IPO opening date is 04 August 2021, and the closing date is 06 August 2021. The issue may list on 17 August 2021.
| IPO Open Date | 04 August 2021 |
| IPO Close Date | 06 August 2021 |
| Basis of Allotment Date | 11 August 2021 |
| Initiation of Refunds | 12 August 2021 |
| Credit of Shares to Demat Account | 13 August 2021 |
| IPO Listing Date | 17 August 2021 |
Basis of Allotment
| Type | % of Offer | Basis of Allotment |
|---|---|---|
| Qualified Institutional Buyer | 75 |
Roughly
equivalent
|
| Non Institutional Investor | 15 |
Roughly
equivalent
|
| Retail | 10 | Minimal level of 1 lot, based on availability, for every shareholder. |
Krsnaa Diagnostics IPO Allotment Status
Allotment of equity stocks subject to the Fresh Issue and transfer of the Promoter Selling Shareholders’ OFS Stocks to the winning Bidders subject to the Offer for Sale. Nevertheless, the status of the allotment has yet to be revealed.
Here, you can find the Allotment Status of Krsnaa Diagnostics IPO.
Krsnaa Diagnostics IPO GMP
Krsnaa Diagnostics IPO Grey Market Premium is as follows and you can check GMP of other IPOs as well from links given below:
| Date | GMP (in Rs) | Subject to Sauda | Kostak (in Rs) |
| 16 August 2021 | |||
| 15 August 2021 | 285 | 4400 | 500 |
| 14 August 2021 | 270 | 5900 | 600 |
| 13 August 2021 | 250 | 5200 | 550 |
| 12 August 2021 | 240 | 3200 | 400 |
| 11 August 2021 | 320 | 2500 | 200 |
| 10 August 2021 | 360 | 3900 | 450 |
| 09 August 2021 | 405 | 2800 | 300 |
| 08 August 2021 | 412 | 3400 | 250 |
| 07 August 2021 | 405 | 2700 | 300 |
| 06 August 2021 | 395 | 5400 | 550 |
| 05 August 2021 | 445 | 4500 | 500 |
| 04 August 2021 | 465 | 3500 | 400 |
| 03 August 2021 | 459 | 2900 | 350 |
| 02 August 2021 | 426 | 2500 | 300 |
| 01 August 2021 | 407 | 1800 | 350 |
| 31 July 2021 | 375 | 1300 | 250 |
Check Out The GMP Of other IPOs
Krsnaa Diagnostics IPO Review
This IPO is for everyone whether you are looking for listing gain or long term view. Apply for listing gain and you can also hold them for a long term as the company is good. Management is also trustworthy & they have a clear vision for growth.
Krsnaa Diagnostics IPO Risk
- Payments under contracts with public health agencies account for a significant component of their operating revenue.
- The majority of their diagnostic centres were built and are run under public-private partnership (PPP) contracts awarded by government entities after a competitive bidding process.
- The COVID-19 pandemic might have a severe impact on their operating results, financial condition, and working capital.
- Business disruption at their diagnostic centres and tele-radiology reporting hub could result in severe losses and damage to their company’s reputation.
- Delays in the opening of diagnostic centres could result in the termination of contracts, which would be negative for the business.
Other Threats
- They are subject to a number of legal and regulatory regulations that regulate their activities, and failure to comply with these requirements could result in significant consequences.
- In India, the diagnostics market is fiercely competitive, and their inability to compete effectively could hurt their firm.
- They may be unable to retain or recruit trained professionals, resulting in a negative influence on their brand’s reputation.
- They rely on third parties for certain areas of their operations, and any shortcomings in their services could have a negative impact on their business.
- In the past, the firm has had declared losses and a negative net worth.
Krsnaa Diagnostics IPO Brokerage views
- Yes Securities : Subscribe
- Choice Brokering: Subscribe
- Axis Securities: Subscribe
- IIFL Securities: Subscribe
- Trade swift: Not Subscribe
- Anand Rathi : Subscribe
- ICICI Securities: Subscribe
Krsnaa Diagnostics IPO Subscription Status
| Date | Day | QIB | NII | Retail | Employees | Total Subscription |
| 04 August 2021 | 1 | 0.48 | 0.15 | 9.59 | 0.00 | 1.98 |
| 05 August 2021 | 2 | 0.50 | 4.76 | 22.09 | 0.00 | 5.42 |
| 06 August 2021 | 3 | 49.83 | 116.30 | 42.04 | 0.98 | 64.40 |
Promoters
- Rajendra Mutha
Promoter Holding
| Pre Issue Share Holding | 61.82% |
| Post Issue Share Holding |
Krsnaa Dignostics IPO Prospectus
Contact Details
Krsnaa Diagnostics Limited
S.No. 243, A-Hissa No. 6, CTS No. 4519, 4519/1, Near Chinchwad Station,
Chinchwad, Taluka – Haveli, Pune – 411 019 India;
Tel: +91 20 4695 4695
E-mail: [email protected];
Website: www.krsnaadiagnostics.com
Registrar
KFin Technologies Private Limited
Selenium Tower-B, Plot 31 & 32, Gachibowli
Financial District, Nanakramguda, Serilingampally
Hyderabad 500 032, Telangana, India
Tel: +91 40 6716 2222
E-mail: [email protected]
Website: www.kfintech.com
Lead Manager(s)
- JM Financial Limited
- DAM Capital Advisors Limited
- Equirus Capital Private Limited
- IIFL Securities Limited
We hope we are able to answer all your questions about Krsnaa Diagnostics IPO. If you don’t have a Demat account, open it now with Zerodha best trading app.
Disclaimer
The reference of IPO Grey Market Premium (IPO GMP) is only valid for the date specified in the header.
On the IPO Grey Market, we do not purchase or sell IPO forms.
The Kostak Rate is the profit earned by selling an IPO application (in an off-market transaction) to somebody else before the issue is allotted or listed.
Do not subscribe to an IPO based solely on the premium price, as it may alter at any time before to the listing. Only consider the fundamentals of the companies when subscribing.
The GMP rates for IPOs are based on market intelligence. Please keep in mind that these IPO GMP rates may vary by geography and market.
Note:
We do not engage in grey market trading or facilitate the purchase or sale of IPO forms.
What is grey Market?
The phrase “grey market” refers to an illegal over-the-counter market where IPO applications and IPO stock are traded before the entity is listed on a stock exchange. This is a technique for dealers to help consumers who wish to sell their home before it goes on the market.
This is also a way to increase the listing fee and provide help for the issue prior to the listing. In the IPO grey market, there are two types of transactions that take place:
- IPO stocks are traded at a premium in the grey market.
- At a kostak, an IPO application is traded.
What is grey Market Premium?
The Grey Market Premium, or GMP, is the price at which IPO stock shares are exchanged in the grey market.
This could be correct or incorrect, implying that the grey market trading price is greater or cheaper than the issue price, depending on demand and supply for the stocks.
Typically, individuals who do not want to incur the risk of their shares not being allocated through an IPO can purchase shares on the grey market in the hopes of flipping them on the IPO for a profit.
What is Kostak?
The additional amount in rupees at which IPO applications are sold in the IPO Grey Market is known as kostak (or price of application). The bonus of a maximum lot retail application in an IPO is generally described as the ‘Kostak’ value.
The Kostak price is significant primarily before the offer is closed for subscription and the ultimate bidding status is made accessible to IPO participants. After the final auction status is known to investors, only a small percentage of IPO applications are exchanged.
‘Kostak’ is made for those who do not want to incur a risk on an IPO or gain from a listing.
Example:
Krsnaa Diagnostics IPO
Issue Price: Rs 306 Per Equity Share (Maximum Bid price)
Lot Size: 45
Grey Market Premium: Rs 220 to Rs 230
Kostak (Rs 13770): Rs 680 to Rs 720
This means Krsnaa Diagnostics IPO of Rs 13770 are being traded in IPO Grey Market at Rs 680 to Rs 720.
Despite the fact that this IPO’s Grey Market Premium is roughly 75% of the issue price, the ‘Kostak’ is just 5% of the application value.
Kostak rate
The Kostak rate is the fee received by an investor who sells his or her IPO application on the grey market. Regardless of allotment status, this is the money an individual stands to gain.
Subject to Sauda
The money that an investor stands to gain by selling his or her application for firm allotment is referred to as the subject to Sauda. Firm allocation is the important operative phrase here. The sauda will be cancelled if the applicant is not allotted.
When selling an IPO application in the grey market, the client and seller agree that the sale will only be legal if the seller receives the allocation. The deal is avoided if the seller does not get any stocks throughout the IPO procedure.
FAQ
Krsnaa Diagnostics IPO Opening Date?
Krsnaa Diagnostics IPO will opening on 04 August 2021.
Krsnaa Diagnostics IPO Allotment Date?
Krsnaa Diagnostics IPO Allotment Date is 11 August 2021.
Krsnaa Diagnostics IPO Listing Date?
Krsnaa Diagnostics IPO Listing date is 17 August 2021
Krsnaa Diagnostics IPO GMP Today?
Krsnaa Diagnostics IPO Grey Market Premium is INR 285.
Krsnaa Diagnostics IPO Price Band?
Krsnaa Diagnostics IPO price Band is 0 to 0.
